Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.

Li XY, Moesta AK, Xiao C, Nakamura K, Casey M, Zhang H, Madore J, Lepletier A, Aguilera AR, Sundarrajan A, Jacoberger-Foissac C, Wong C, Dela Cruz T, Welch M, Lerner AG, Spatola BN, Soros VB, Corbin J, Anderson AC, Effern M, Hölzel M, Robson SC, Johnston RL, Waddell N, Smith C, Bald T, Geetha N, Beers C, Teng MWL, Smyth MJ.

Cancer Discov. 2019 Dec;9(12):1754-1773. doi: 10.1158/2159-8290.CD-19-0541. Epub 2019 Nov 7.

PMID:
31699796
2.

Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.

Martinotti G, Santacroce R, Pettorruso M, Montemitro C, Spano MC, Lorusso M, di Giannantonio M, Lerner AG.

Brain Sci. 2018 Mar 16;8(3). pii: E47. doi: 10.3390/brainsci8030047. Review.

3.

Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use.

Lev-Ran S, Feingold D, Goodman C, Lerner AG.

Am J Addict. 2017 Sep;26(6):568-571. doi: 10.1111/ajad.12577. Epub 2017 Jun 27.

PMID:
28654720
4.

A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD.

Halpern JH, Lerner AG, Passie T.

Curr Top Behav Neurosci. 2018;36:333-360. doi: 10.1007/7854_2016_457. Review.

PMID:
27822679
5.

Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits.

Acosta-Alvear D, Cho MY, Wild T, Buchholz TJ, Lerner AG, Simakova O, Hahn J, Korde N, Landgren O, Maric I, Choudhary C, Walter P, Weissman JS, Kampmann M.

Elife. 2015 Sep 1;4:e08153. doi: 10.7554/eLife.08153.

6.

Type 2 diabetes and cardiac autonomic neuropathy screening using dynamic pupillometry.

Lerner AG, Bernabé-Ortiz A, Ticse R, Hernandez A, Huaylinos Y, Pinto ME, Málaga G, Checkley W, Gilman RH, Miranda JJ; CRONICAS Cohort Study Group.

Diabet Med. 2015 Nov;32(11):1470-8. doi: 10.1111/dme.12752. Epub 2015 Apr 7.

7.

Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigation.

Lev-Ran S, Feingold D, Frenkel A, Lerner AG.

J Dual Diagn. 2014;10(2):79-83. doi: 10.1080/15504263.2014.906155.

PMID:
25392249
8.

The "rule of halves" does not apply in Peru: awareness, treatment, and control of hypertension and diabetes in rural, urban, and rural-to-urban migrants.

Lerner AG, Bernabe-Ortiz A, Gilman RH, Smeeth L, Miranda JJ.

Crit Pathw Cardiol. 2013 Jun;12(2):53-8. doi: 10.1097/HPC.0b013e318285ef60.

9.

IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress.

Lerner AG, Upton JP, Praveen PV, Ghosh R, Nakagawa Y, Igbaria A, Shen S, Nguyen V, Backes BJ, Heiman M, Heintz N, Greengard P, Hui S, Tang Q, Trusina A, Oakes SA, Papa FR.

Cell Metab. 2012 Aug 8;16(2):250-64. doi: 10.1016/j.cmet.2012.07.007.

10.
11.

Surgical perspectives from a prospective, nonrandomized, multicenter study of breast conserving surgery and adjuvant electronic brachytherapy for the treatment of breast cancer.

Dooley WC, Algan O, Dowlatshahi K, Francescatti D, Tito E, Beatty JD, Lerner AG, Ballard B, Boolbol SK.

World J Surg Oncol. 2011 Mar 7;9:30. doi: 10.1186/1477-7819-9-30.

12.

IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates.

Han D, Lerner AG, Vande Walle L, Upton JP, Xu W, Hagen A, Backes BJ, Oakes SA, Papa FR.

Cell. 2009 Aug 7;138(3):562-75. doi: 10.1016/j.cell.2009.07.017.

13.

Who should perform image-guided breast biopsy and treatment?

Dowlatshahi K, Snider H, Lerner AG.

Am J Surg. 2007 Sep;194(3):275-7. No abstract available.

PMID:
17693264
14.
15.

Who are we and what do we think?

Beitsch PD, Lerner AG, Laidley AL, Tafra L, Edwards MJ.

Am J Surg. 2003 Oct;186(4):321-3.

PMID:
14553842
16.

Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features.

Lerner AG, Gelkopf M, Skladman I, Rudinski D, Nachshon H, Bleich A.

Int Clin Psychopharmacol. 2003 Mar;18(2):101-5.

PMID:
12598822
17.

Understanding breast surgery economics.

Lerner AG.

Am J Surg. 2002 Oct;184(4):297-8. No abstract available.

PMID:
12383886
18.

Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach.

Lerner AG, Gelkopf M, Skladman I, Oyffe I, Finkel B, Sigal M, Weizman A.

Isr J Psychiatry Relat Sci. 2002;39(2):92-9. Review.

PMID:
12227234
19.

LSD-induced Hallucinogen Persisting Perception Disorder with depressive features treated with reboxetine: case report.

Lerner AG, Shufman E, Kodesh A, Kretzmer G, Sigal M.

Isr J Psychiatry Relat Sci. 2002;39(2):100-3.

PMID:
12227224
20.

Risperidone-associated, benign transient visual disturbances in schizophrenic patients with a past history of LSD abuse.

Lerner AG, Shufman E, Kodesh A, Rudinski D, Kretzmer G, Sigal M.

Isr J Psychiatry Relat Sci. 2002;39(1):57-60.

PMID:
12013711
21.

Importance of quality breast imaging in symptomatic women.

Burak WE Jr, Lerner AG.

Radiology. 2002 Mar;222(3):856; author reply 856-7. No abstract available.

PMID:
11867813
22.

LSD-induced Hallucinogen Persisting Perception Disorder treated with clonazepam: two case reports.

Lerner AG, Skladman I, Kodesh A, Sigal M, Shufman E.

Isr J Psychiatry Relat Sci. 2001;38(2):133-6.

PMID:
11475916
23.

Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder.

Kodesh A, Katz S, Lerner AG, Finkel B, Sigal M.

J Psychopharmacol. 2001 Mar;15(1):58-60.

PMID:
11277610
24.

Dose-dependent olanzapine-associated leukopenia: three case reports.

Kodesh A, Finkel B, Lerner AG, Kretzmer G, Sigal M.

Int Clin Psychopharmacol. 2001 Mar;16(2):117-9.

PMID:
11236070
25.

LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study.

Lerner AG, Gelkopf M, Oyffe I, Finkel B, Katz S, Sigal M, Weizman A.

Int Clin Psychopharmacol. 2000 Jan;15(1):35-7.

PMID:
10836284
26.

Clonidine treatment for hallucinogen persisting perception disorder.

Lerner AG, Finkel B, Oyffe I, Merenzon I, Sigal M.

Am J Psychiatry. 1998 Oct;155(10):1460. No abstract available.

PMID:
9766785
27.

Risperidone-associated agranulocytosis.

Finkel B, Lerner AG, Oyffe I, Sigal M.

Am J Psychiatry. 1998 Jun;155(6):855-6. No abstract available.

PMID:
9619165
28.

Naltrexone-induced reduction of tobacco intake.

Lerner AG, Oyffe I, Sigal M.

J Clin Psychiatry. 1998 Jan;59(1):30-1. No abstract available.

PMID:
9491065
29.

Naltrexone treatment of hallucinogen persisting perception disorder.

Lerner AG, Oyefe I, Isaacs G, Sigal M.

Am J Psychiatry. 1997 Mar;154(3):437. No abstract available.

PMID:
9054801
30.

Home-based inpatient treatment vs. outpatient day clinic treatment: a preliminary report in opiate-dependent patients.

Lerner AG, Gelkopf M, Oyffe I, Sigal M.

J Nerv Ment Dis. 1995 Nov;183(11):715. No abstract available.

PMID:
7595435
31.

Naltrexone abuse and risk of suicide.

Lerner AG, Sigal M, Gelkopf M.

J Nerv Ment Dis. 1993 Nov;181(11):706-7. No abstract available.

PMID:
8228955
32.

Naltrexone abuse potential.

Lerner AG, Sigal M, Bocalu A, Gelkopf M.

J Nerv Ment Dis. 1992 Nov;180(11):734-5. No abstract available.

PMID:
1431829
33.

Bouveret's syndrome presenting as upper gastrointestinal hemorrhage.

Chait MM, Lerner AG.

Am J Gastroenterol. 1986 Dec;81(12):1199-201.

PMID:
3491539
34.

Adenoid cystic carcinoma of the breast.

Lerner AG, Molnar JJ, Adam YG.

Am J Surg. 1974 May;127(5):585-7. No abstract available.

PMID:
4362663
35.

Selective intra-arterial vasopressin in the management of stress ulcers in childhood.

Lerner AG, Meng CH, Schneider KM.

Pediatrics. 1973 Jan;51(1):126-8. No abstract available.

PMID:
4684434
36.

An integrated procedure for the rapid diagnosis of biliary obstruction, portal hypertension and liver disease of uncertain etiology.

Strack PR, Newman HK, Lerner AG, Green SH, Meng CH, Del Guercio LR, State D.

N Engl J Med. 1971 Nov;285(22):1225-31. No abstract available.

PMID:
5113711
37.

Physical class and physiologic status in the prediction of operative mortality in the aged sick.

Lewin I, Lerner AG, Green SH, Del Guercio LR, Siegel JH.

Ann Surg. 1971 Aug;174(2):217-31. No abstract available.

Supplemental Content

Loading ...
Support Center